Skip to main content
. 2021 Nov 25;107(9):2121–2132. doi: 10.3324/haematol.2021.279948

Figure 4.

Figure 4.

von Willebrand factor antigen levels, free A1-domains and factor VIII activity (%) afer multiple doses of BT200. Subjects received 12 mg BT200 intravenously plus 12 mg subcutaneously on the first day and 12 mg subcutaneously weekly or placebo. Data are presented as mean values with 95% confidence intervals (n=6 for BT200 groups, n=20 for placebo). VWF: von Willebrand factor; Ag: antigen; FVIIIc: factor VIII activity.